Literature DB >> 12209993

Role for beta3 integrins in human melanoma growth and survival.

Mohit Trikha1, Jozsef Timar, Alex Zacharek, Jeffrey A Nemeth, Yinlong Cai, Balazs Dome, Beata Somlai, Elisabeth Raso, Andrea Ladanyi, Kenneth V Honn.   

Abstract

The role of alphaIIbbeta3 integrin in regulating platelet function is well appreciated, whereas its role in tumor progression and metastasis is not. The purpose of our study was to determine a functional relevance to expression of alphaIIbbeta3 integrin in cells derived from human solid tumors. A study of human melanoma biopsies (n = 24) showed that alphaIIbbeta3 expression increased with tumor thickness, which is indicative of metastatic propensity. Expression of alphaIIbbeta3 was 8% (+/-1.8), 33% (+/-10.4) and 62% (+/-5) in melanomas ranging in thickness from 0-1.5 mm, 1.5-4.0 mm and >4 mm, respectively; alphavbeta3 was equally high all categories. To determine biological function, we stably transfected alphaIIbbeta3 into human melanoma cells that express alphavbeta3, but not alphaIIbbeta3. Surface expression of alphavbeta3 remained unaltered between alphaIIbbeta3 (+) and mock transfected counterparts. The alphaIIbbeta3 (+) cells possessed increased ability to adhere, spread and migrate on fibrinogen. They had decreased ability to attach, spread and migrate on vitronectin. Immunocytochemistry showed that expression of alphaIIbbeta3 displaced alphavbeta3 from focal contact points. When implanted subcutaneously into SCID mice, the alphaIIbbeta3 (+) cells developed approximately 4-fold larger tumors when compared to their mock counterparts and the level of apoptosis was reduced within the tumors. Results suggest that co-expression of the 2 beta3 integrins, alphavbeta3 and alphaIIbbeta3, in human melanoma cells enhanced cell survival and promoted growth in vivo. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209993     DOI: 10.1002/ijc.10521

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

Review 1.  Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?

Authors:  József Tímár; Balázs Gyorffy; Erzsébet Rásó
Journal:  Clin Exp Metastasis       Date:  2010-02-24       Impact factor: 5.150

2.  Inhibition of experimental metastasis by targeting the HUIV26 cryptic epitope in collagen.

Authors:  Jennifer M Roth; Maresa Caunt; Alexandra Cretu; Abebe Akalu; Desiree Policarpio; Xiaolu Li; Paul Gagne; Silvia Formenti; Peter C Brooks
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

3.  Embryonic vasculogenesis in nodular melanomas and tumour differentiation.

Authors:  Bhanu Iyengar; Avantika V Singh
Journal:  Pathol Oncol Res       Date:  2011-01-04       Impact factor: 3.201

4.  Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest.

Authors:  Bíborka Bereczky; Réka Gilly; Erzsébet Rásó; Agnes Vágó; József Tímár; József Tóvári
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 5.  Blastocysts don't go it alone. Extrinsic signals fine-tune the intrinsic developmental program of trophoblast cells.

Authors:  D Randall Armant
Journal:  Dev Biol       Date:  2005-04-15       Impact factor: 3.582

6.  Expression order of alpha-v and beta-3 integrin subunits in the N-methyl-N-nitrosourea-induced rat mammary tumor model.

Authors:  Robabeh Rezaeipoor; Eric J Chaney; Amy L Oldenburg; Stephen A Boppart
Journal:  Cancer Invest       Date:  2009-06       Impact factor: 2.176

7.  Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer.

Authors:  P Bohanes; D Yang; F Loupakis; M J LaBonte; A Gerger; Y Ning; C Lenz; F Lenz; T Wakatsuki; W Zhang; L Benhaim; A El-Khoueiry; R El-Khoueiry; H-J Lenz
Journal:  Pharmacogenomics J       Date:  2014-12-09       Impact factor: 3.550

8.  Correlation of integrin beta3 mRNA and vascular endothelial growth factor protein expression profiles with the clinicopathological features and prognosis of gastric carcinoma.

Authors:  Shu-Guang Li; Zai-Yuan Ye; Zhong-Sheng Zhao; Hou-Quan Tao; Yuan-Yu Wang; Chun-Yu Niu
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

9.  Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas.

Authors:  Ingeborg M Bachmann; Rita G Ladstein; Oddbjørn Straume; George N Naumov; Lars A Akslen
Journal:  BMC Cancer       Date:  2008-12-05       Impact factor: 4.430

10.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.